Navigation Links
FRC Action and Pro-Life Coalition Urge the FDA to Reject New Abortion-Causing Drug
Date:7/28/2010

WASHINGTON, July 28 /PRNewswire-USNewswire/ -- Today FRC Action joined 19 pro-life groups in a letter sent to Food and Drug Administration (FDA) Commissioner Margaret Hamburg requesting that Ella, a drug under consideration for FDA approval that can cause abortions but is misleadingly labeled as an "emergency contraceptive," not be approved.

Tom McClusky, FRC Action's Senior Vice President, made the following comments:

"The Obama Administration has repeatedly promised a commitment to science and transparency, but approval of Ella as an 'emergency contraceptive' would deny women the right to informed consent on something as important as a baby's life and their health. Ella can cause an abortion after implantation, just like RU-486.

"Additionally, given the recently enacted Obama health care plan, approval of this drug could open yet another backdoor to taxpayer funding of abortions," McClusky concluded.

Click here to download FRC's new Ella fact sheet, "Myth and Fact: The Truth About Ella and How it Works."

http://www.frc.org/get.cfm?i=IF10G01

Click here to download a copy of the group letter to FDA Commissioner Margaret Hamburg.

http://www.frc.org/ella-group-letter


'/>"/>
SOURCE Family Research Council Action
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
2. NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease
3. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
4. AIDS Action Council Statement on World AIDS Day 2007: Leadership Needed for a National Strategy to Stop the AIDS Epidemic
5. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
6. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
7. Study Linking Increased Risk of Death to Severe Psoriasis a Call to Action
8. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
9. ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI
10. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
11. Genmab A/S - Company Announcement: Novel Insights into HuMax-EGFr Mechanisms of Action Published in PNAS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... 4, 2016 Research ... "Global Acute Myeloid Leukemia Market and Competitive ... offering.       (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO ... Market and Competitive Landscape Highlights 2016, provides ... products, Acute Myeloid Leukemia epidemiology, Acute Myeloid ...
(Date:5/3/2016)... Global Insulin Needles Industry ... key companies and supported with 272 tables and ... on the current state of the Insulin Needles ... including definitions, classifications, applications and industry chain structure. ... the international market including development history, competitive landscape ...
(Date:5/3/2016)... May 3, 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand product development, ... - http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... ... From May 4 to 6, EarQ and Signia co-sponsored a ... more about Signia’s technology and the successful business and marketing techniques that make EarQ ... practices succeed in this highly competitive industry,” said Ed Keller, president of EarQ. “This ...
(Date:5/6/2016)... Diego, CA (PRWEB) , ... May 06, 2016 , ... ... Companies, has been family-owned and operated for over 35 years. Maintaining core values of ... has driven their success and made them a leading name in San Diego plumbing, ...
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... ... System and David Konur, CEO of Cardiovascular Institute of the South announced today ... be performing a live case of an Intravascular Ultrasound Guided Coronary Atherectomy. ...
(Date:5/5/2016)... ... May 05, 2016 , ... Pivot Point Consulting ... gold standard KLAS Performance Report, Epic Consulting 2016 - Which Firms ... specialize in consulting services for electronic health record (EHR) solutions from Epic ...
(Date:5/5/2016)... Tampa, FL (PRWEB) , ... May 05, 2016 ... ... hospital in Tampa to offer patients with non-valvular atrial fibrillation (A-Fib) an alternative ... (LAAC) Implant. Since first offering the procedure in April of 2015, Florida Hospital ...
Breaking Medicine News(10 mins):